Kiniksa Pharmaceuticals (KNSA) Insider Trading & Ownership $20.49 +0.17 (+0.84%) (As of 12/17/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Kiniksa Pharmaceuticals (NASDAQ:KNSA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage54.57%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$9.29 M Get KNSA Insider Trade Alerts Want to know when executives and insiders are buying or selling Kiniksa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KNSA Insider Buying and Selling by Quarter Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. Kiniksa Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/5/2024Mark RagosaCFOSell1,123$21.25$23,863.75 12/3/2024Mark RagosaCFOSell8,969$21.45$192,385.05 10/15/2024Eben TessariCOOSell17,000$26.87$456,790.00 9/23/2024Eben TessariCOOSell17,500$24.99$437,325.00 9/3/2024John F PaoliniInsiderSell60,692$26.12$1,585,275.04 8/27/2024Eben TessariCOOSell17,500$26.91$470,925.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/23/2024John F PaoliniInsiderSell22,000$26.32$579,040.00 7/23/2024Mark RagosaCFOSell24,248$24.79$601,107.92 7/23/2024Sanj K PatelCEOSell136,124$25.65$3,491,580.60 3/6/2024Sanj K PatelCEOSell5,582$21.00$117,222.00 3/4/2024Sanj K PatelCEOSell12,742$21.49$273,825.58 3/1/2024Michael R MegnaCAOSell9,659$21.45$207,185.55 2/28/2024Michael R MegnaCAOSell5,126$21.79$111,695.54 1/3/2024Mark RagosaCFOSell12,000$20.00$240,000.00 1/2/2024Michael R MegnaCAOSell16,670$19.17$319,563.90 12/19/2023Michael R MegnaCAOSell9,316$19.13$178,215.08 (Data available from 1/1/2013 forward) KNSA Insider Trading Activity - Frequently Asked Questions Who is on Kiniksa Pharmaceuticals's Insider Roster? The list of insiders at Kiniksa Pharmaceuticals includes Barry D. Quart, Eben Tessari, John F Paolini, Mark Ragosa, Michael R Megna, and Sanj K Patel. Learn more on insiders at KNSA. What percentage of Kiniksa Pharmaceuticals stock is owned by insiders? 54.57% of Kiniksa Pharmaceuticals stock is owned by insiders. Learn more on KNSA's insider holdings. Which Kiniksa Pharmaceuticals insiders have been selling company stock? The following insiders have sold KNSA shares in the last 24 months: Eben Tessari ($1,365,040.00), John F Paolini ($3,231,177.04), Mark Ragosa ($1,057,356.72), Michael R Megna ($816,660.07), and Sanj K Patel ($3,882,628.18). How much insider selling is happening at Kiniksa Pharmaceuticals? Insiders have sold a total of 434,251 Kiniksa Pharmaceuticals shares in the last 24 months for a total of $10,352,862.01 sold. Kiniksa Pharmaceuticals Key ExecutivesMr. Sanj K. Patel (Age 55)CEO & Chairman of the Board Compensation: $1.57M1 recent tradesMr. Eben Tessari (Age 42)Senior VP & COO Compensation: $733.29k3 recent tradesDr. John F. Paolini FACC (Age 59)M.D., Ph.D., Senior VP & Chief Medical Officer Compensation: $855.79kMr. Mark Ragosa C.F.A. (Age 50)Senior VP & CFO Mr. Michael R. Megna CPA (Age 53)Chief Accounting Officer & Group VP of Finance Mr. Chad MorinSenior VP & Chief Compliance OfficerMs. Madelyn Demsky Zeylikman (Age 50)SVP, General Counsel & Secretary More Insider Trading Tools from MarketBeat Related Companies CYTK Insider Transactions TGTX Insider Transactions VKTX Insider Transactions BBIO Insider Transactions CRNX Insider Transactions KRYS Insider Transactions ACLX Insider Transactions ADMA Insider Transactions RARE Insider Transactions BHVN Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:KNSA) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiniksa Pharmaceuticals, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiniksa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
